1. Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y et al (2008) 8-Hydroxy-2’-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 23(9):1431–1436
2. Eissa SA, Abdel Meguid LM, Ebeid SM, Abou Elfetouh RM, Abdel Moneim GM (2007) National Cancer Institute experience in healthy Egyptian blood donors as regards blood group frequencies and seroprevalence of hepatitis b virus, hepatitis C Virus & HIV: 10 year evaluation. J Egypt Natl Cancer Inst 19(1):71–76
3. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK (2006) Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health 50(1):43–44
4. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ et al (2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 9(4):319–323
5. Vermehren J, Kau A, Gartner BC, Gobel R, Zeuzem S, Sarrazin C (2008) Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification. J Clin Microbiol 46(12):3880–3891